Showing results (161-170 of 184) with videos related to
Sort By:
Pageof 19
Cancer Gene Therapy|July 31, 2001
Tricistronic viral vectors co-expressing interleukin-12 (1L-12) and CD80 (B7-1) for the immunotherapy of cancer: preclinical studies in myelomaX Y Wen, S Mandelbaum, Z H Li, et al.Human Gene Therapy|February 4, 1998
Enhanced immunogenicity of B cell lymphoma genetically engineered to express both B7-1 and interleukin-12E Pizzoferrato, N R Chu, T S Hawley, et al.Blood|April 6, 2001
The myeloma-associated oncogene fibroblast growth factor receptor 3 is transforming in hematopoietic cellsZ Li, Y X Zhu, E E Plowright, et al.Nature|February 3, 1994
Inhibition of nuclear hormone receptor activity by calreticulinS Dedhar, P S Rennie, M Shago, et al.Blood|May 15, 1995
SBH-1, a novel Reed-Sternberg-like cell line capable of inducing tumors in SCID mice: immunophenotypic, cytogenetic, and cytokine expression profilesJ F DeCoteau, M D Reis, H Griesser, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1995
Prevention of autoimmune disease by retroviral-mediated gene therapyB A Ally, T S Hawley, K J McKall-Faienza, et al.Oncogene|January 11, 2007
TLX1/HOX11-induced hematopoietic differentiation blockadeI Riz, S S Akimov, S S Eaker, et al.Oncogene|November 2, 2004
Tissue inhibitor of matrix metalloproteinase-1 overexpression in M1 myeloblasts impairs IL-6-induced differentiationPeter Haviernik, Carisa Lahoda, Heath L Bradley, et al.Genomics|June 20, 1998
Identification of sequence-tagged transcripts differentially expressed within the human hematopoietic hierarchyJ O Claudio, C C Liew, A A Dempsey, et al.Oncogene|March 4, 1998
BCR-ABL and constitutively active erythropoietin receptor (cEpoR) activate distinct mechanisms for growth factor-independence and inhibition of apoptosis in Ba/F3 cell lineM Ahmed, I Dusanter-Fourt, M Bernard, et al.Pageof 19